0
Your cart

Your cart is empty

Books > Professional & Technical > Biochemical engineering > Biotechnology

Buy Now

Systems Biology in Biotech & Pharma - A Changing Paradigm (Paperback, 2012 ed.) Loot Price: R1,426
Discovery Miles 14 260
Systems Biology in Biotech & Pharma - A Changing Paradigm (Paperback, 2012 ed.): Ales Prokop, Seth Michelson

Systems Biology in Biotech & Pharma - A Changing Paradigm (Paperback, 2012 ed.)

Ales Prokop, Seth Michelson

Series: SpringerBriefs in Pharmaceutical Science & Drug Development

 (sign in to rate)
Loot Price R1,426 Discovery Miles 14 260 | Repayment Terms: R134 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Systems Biology (SB) is a suite of technologies and methodologies that resulted, conceptually from the merging of two basic paradigms, reductionism and holism with the goal of identifying its emergent properties and defining, quantitatively, molecular, cellular, tissue, organ and whole body processes. One manifestation of SB is as a tool for hypothesis generation about a system that is typically too large and complex to understand by simple reasoning.

The US is currently well ahead of the rest of the world in the development and application of SB and its principles especially as they pertain to basic medical research and development.This lead is largely due to its earlier start in the academic arena. However, there is evidence of rapid development in both the UK/EU and Japan, and the gap is narrowing, particularly in the UK. From an industrial point of view, the Pharmaceutical Industry based in the US and UK can capitalize on these opportunities and gain the benefits of this technology. Many educational institutions (particularly their medical divisions) at present are heavily business-oriented, realize that in this particular industrial environment, that every dollar counts.

This book intends to educate Cell and Molecular Biologists in the use of the quantitative tools that are available to them to help solve the critical problems they face. It is important that biologists recognize early in their research the use and benefits of SB and how this approach can help to generate new therapeutic leads and substances useful for human health. Educational curricula in the life sciences have typically been based on the belief that one can dissect complex systems into their components and that a detailed investigation of each these components individually will in itself lead to novel biological insights, and indeed this is true in numerous instances. However, increasing acknowledgment of the importance of studying whole systems, as well as their components, has led to an emphasis on teaching not just a reductionist view of biology, but also a complementary constructionist view.

General

Imprint: Springer
Country of origin: Netherlands
Series: SpringerBriefs in Pharmaceutical Science & Drug Development
Release date: 2012
First published: 2012
Authors: Ales Prokop • Seth Michelson
Dimensions: 235 x 155 x 8mm (L x W x T)
Format: Paperback
Pages: 127
Edition: 2012 ed.
ISBN-13: 978-9400728486
Categories: Books > Medicine > General issues > Medical equipment & techniques > Medical research
Books > Professional & Technical > Biochemical engineering > Biotechnology > General
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN: 9400728484
Barcode: 9789400728486

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners